Correlation Between Salesforce and Jafron Biomedical
Specify exactly 2 symbols:
By analyzing existing cross correlation between Salesforce and Jafron Biomedical Co, you can compare the effects of market volatilities on Salesforce and Jafron Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Jafron Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Jafron Biomedical.
Diversification Opportunities for Salesforce and Jafron Biomedical
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Salesforce and Jafron is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Jafron Biomedical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jafron Biomedical and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Jafron Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jafron Biomedical has no effect on the direction of Salesforce i.e., Salesforce and Jafron Biomedical go up and down completely randomly.
Pair Corralation between Salesforce and Jafron Biomedical
Considering the 90-day investment horizon Salesforce is expected to generate 1.0 times more return on investment than Jafron Biomedical. However, Salesforce is 1.0 times more volatile than Jafron Biomedical Co. It trades about 0.23 of its potential returns per unit of risk. Jafron Biomedical Co is currently generating about -0.05 per unit of risk. If you would invest 29,801 in Salesforce on September 3, 2024 and sell it today you would earn a total of 3,198 from holding Salesforce or generate 10.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Salesforce vs. Jafron Biomedical Co
Performance |
| Timeline |
| Salesforce |
| Jafron Biomedical |
Salesforce and Jafron Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Jafron Biomedical
The main advantage of trading using opposite Salesforce and Jafron Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Jafron Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jafron Biomedical will offset losses from the drop in Jafron Biomedical's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Jafron Biomedical vs. Chengdu Kanghua Biological | Jafron Biomedical vs. Beijing Wantai Biological | Jafron Biomedical vs. Suzhou Novoprotein Scientific | Jafron Biomedical vs. Aluminum Corp of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |